Pacira Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
September 01 2016 - 7:30AM
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that
Dave Stack, Chief Executive Officer and Chairman of Pacira
Pharmaceuticals, is scheduled to present at the Morgan Stanley
Global Healthcare Conference at 11:05 a.m. ET on Monday, September
12, 2016, in New York. Mr. Stack is expected to present an overview
of the company.
A live audio webcast of the Pacira presentation can
be accessed by visiting the “Investors & Media” section of the
company’s website at investor.pacira.com. A replay of the webcast
will be archived on the Pacira website for two weeks following the
presentation date.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s flagship product,
EXPAREL® (bupivacaine liposome injectable suspension), indicated
for single-dose infiltration into the surgical site to produce
postsurgical analgesia, was commercially launched in the United
States in April 2012. EXPAREL and two other products have
successfully utilized DepoFoam®, a unique and proprietary product
delivery technology that encapsulates drugs without altering their
molecular structure, and releases them over a desired period of
time. Additional information about Pacira is available at
www.pacira.com.
Company Contact:
Pacira Pharmaceuticals, Inc.
Jessica Cho, (973) 254-3574
jessica.cho@pacira.com
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Apr 2023 to Apr 2024